Download PDF

Other users also viewed these articles

Clinical effectiveness and safety of vedolizumab versus infliximab in biologic-naïve patients with ulcerative colitis: A comparative real-world multicentric observational study Sandro da Costa Ferreira; Rogério Serafim Parra; Ligia Yukie Sassaki; José Miguel Luz Parente; Munique Kurtz de Mello; Liliana Andrade Chebli; Rafael Luís Luporini; Antonio José Tiburcio Alves Junior; Fernando Jorge Firmino Nóbrega; Bruno César da Silva; Eron Fábio Miranda; Abel Botelho Quaresma; Guilherme Mattioli Nicollelli; Rodrigo Galhardi Gasparini; Renata de Medeiros Dutra; Juarez Roberto de Oliveira Vasconcelos; Katia da Conceição da Silva; Daniéla Oliveira Magro; Marcello Rabello Imbrizi; Cristiane Kibune Nagasako; Omar Féres; Luiz Ernesto de Almeida Troncon; Paulo Gustavo Kotze; Júlio Maria Fonseca Chebli;
Gastroenterol Hepatol. 2025;48:
Nationwide trends in colectomy rates for ulcerative colitis in Brazil: An analysis of the unified public healthcare system Mariane Christina Savio; Julia Ceconello Coelho; Emilia Oliveira; Daniela Oliveira Magro; Douglas Andreas Valverde; Abel Botelho Quaresma; Rafaela de Araujo Molteni; Maria Paz Gimenez Villamil; Paulo Gustavo Kotze;
Gastroenterol Hepatol. 2025;48: